Union Health Ministry allocates ₹531 crore for health research, AI, and new therapies in Union Budget 2025. (Source: iStock image)
The Union Health Ministry’s Department of Health Research has been allocated an enhancement fund of `531 crore in the Union Budget which it will invest over the next five years in areas such as artificial intelligence in healthcare and development of newer therapies.
“There has been an 18% increase in the budget for the Department of Health Research this year. And, over the last decade, the budget has grown nearly four-fold. Importantly, in this budget, we have received a `531-crore special enhancement for the next five years,” said Dr Rajiv Bahl, Director General, Indian Council of Medical Research (ICMR).
You have exhausted your monthly limit of free stories.
Read more stories for free with an Express account.
Some other key areas where the money will go are: tackling persistent health problems such as anaemia and cancers, research implementation, pandemic preparedness and ensuring that Indian institutes rank high in medical research.
When it comes to digital health and AI, Dr Bahl said the department will support the development of new tools and databases on which these tools would be developed and trained.
Dr Bahl said ICMR will support the development of newer therapies such as gene therapy and help take them to the market.
The ICMR, along with NITI Aayog and the apex drug regulator CDSCO, also plans to help startups making medical devices during multiple phases of development: pre-clinical and clinical trials, regulatory approvals, prototype development and scaling up
In the case of pandemic preparedness, the government will work towards setting up the National Institute of One Health, improve facilities for surveillance such as setting up of biosafety level 3 and 4 laboratories, and creating a network between already existing laboratories under various government institutions. The department of health research will also work towards developing medical countermeasures against pathogens that may lead to outbreaks and pandemics. The department plans to create libraries of these countermeasures.
Story continues below this ad
“We are working on developing a vaccine against Kyasanur Forest Disease and a monoclonal antibody for Nipah. We have already developed and made available in the market diagnostic tests for Mpox,” said Dr Bahl.
Kyasanur Forest Disease is a tick-borne infection that causes fever, nausea, vomiting, diarrhoea, and in some cases neurological and bleeding symptoms. It kills 3% to 5% people it infects. And, Nipah is a viral infection usually transmitted by infected bats. It may lead to fatal brain swelling, with the disease killing 40% to 75% of those who test positive.
Anonna Dutt is a Principal Correspondent who writes primarily on health at the Indian Express. She reports on myriad topics ranging from the growing burden of non-communicable diseases such as diabetes and hypertension to the problems with pervasive infectious conditions. She reported on the government’s management of the Covid-19 pandemic and closely followed the vaccination programme.
Her stories have resulted in the city government investing in high-end tests for the poor and acknowledging errors in their official reports.
Dutt also takes a keen interest in the country’s space programme and has written on key missions like Chandrayaan 2 and 3, Aditya L1, and Gaganyaan.
She was among the first batch of eleven media fellows with RBM Partnership to End Malaria. She was also selected to participate in the short-term programme on early childhood reporting at Columbia University’s Dart Centre. Dutt has a Bachelor’s Degree from the Symbiosis Institute of Media and Communication, Pune and a PG Diploma from the Asian College of Journalism, Chennai. She started her reporting career with the Hindustan Times.
When not at work, she tries to appease the Duolingo owl with her French skills and sometimes takes to the dance floor. ... Read More